Page 7 - Centric Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Middle East & Africa s pharma industry IT hiring activity rises 6 7% in June 2022

Middle East & Africa witnessed a 6.7% rises in IT hiring activity in the pharma industry in June 2022, according to GlobalData’s Job Analytics index

South africaParexel internationalCentric services forElectronic data capture solutions for clinical trialsNetwork administratorsCardinal healthWeb developersMiddle eastJob analyticsTesters occupationsComputer occupationsInformation analystsHealtheast care systemEntry levelCentric servicesAlternate site clinical trials

Germany s pharma industry IT recruitment activity drops 9 9% in June 2022

Germany’s pharma industry registered a 9.9% drops in IT hiring activity in June 2022, according to GlobalData

Fresenius sekgaCentric services forElectronic data capture solutions for clinical trialsNetwork administratorsBoehringer ingelheim internationalWeb developersJob analyticsInformation analystsMiscellaneous computer occupationsEntry levelCentric servicesAlternate site clinical trialsData capture solutions

Asia-Pacific sees hiring bump in clinical trial operations data analytics roles

Asia-Pacific sees hiring bump in clinical trial operations data analytics roles
clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.

United statesCentric services forSample servicesTime data services for clinical researchSan diegoTime data servicesClinical researchCentric servicesAlternate site clinical trialsClinical supplyBiological sample

Familial hypercholesterolemia screening may reduce coronary artery disease prevalence

Coronary artery disease is expected to impact roughly 13.1 million individuals over the age of 19 in the US this year.

United statesCentric services forContract manufacturing organisationJournal of the american heart associationDutch lipid clinic networkAmerican heart associationUnited kingdom biobankCentric servicesAlternate site clinical trialsManufacturing organisationPharmaceutical supply

AffaMed announces dosing of first subject in retinal disease therapy trial

AffaMed Therapeutics has announced dosing of the first subject in the Phase I clinical trial of AM712 to treat retinal diseases in the US.

Askgene pharmaDayao zhaoCentric services forContract manufacturing organisationDrug administrationTime data services for clinical researchAffamed therapeuticsInvestigational new drugCentric servicesAlternate site clinical trialsManufacturing organisationPharmaceutical supplyTime data servicesClinical research